Vaxcyte
PCVX
Vaxcyte (PCVX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Maintained | Overweight | $120.00 | Oct 12, 2026 |
| Guggenheim | Maintained | Buy | $125.00 from $116.00 | Oct 5, 2026 |
| Needham | Maintained | Buy | $122.00 from $110.00 | Oct 5, 2026 |
| BTIG | Maintained | Buy | $89.00 | Oct 5, 2026 |
| B of A Securities | Maintained | Buy | $130.00 from $133.00 | Sep 28, 2026 |
| Needham | Maintained | Buy | $110.00 | Sep 25, 2026 |
| BTIG | Maintained | Buy | $89.00 from $85.00 | Feb 26, 2026 |
| Guggenheim | Maintained | Buy | $116.00 | Feb 2, 2026 |
| Needham | Maintained | Buy | $110.00 from $90.00 | Jan 7, 2026 |
| BTIG | Maintained | Buy | $85.00 | Nov 10, 2025 |
| Goldman Sachs | Initiated Coverage | Neutral | $38.00 | Sep 12, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Apr 22, 2025 |
| Needham | Maintained | Buy | $90.00 | Apr 8, 2025 |
| Needham | Maintained | Buy | $90.00 from $140.00 | Apr 1, 2025 |
| B of A Securities | Maintained | Buy | $137.00 from $157.00 | Apr 1, 2025 |
| Goldman Sachs | Maintained | Buy | $100.00 from $138.00 | Apr 1, 2025 |
| Guggenheim | Maintained | Buy | $160.00 | Mar 12, 2025 |
| Needham | Maintained | Buy | $140.00 | Feb 26, 2025 |
| Guggenheim | Maintained | Buy | $160.00 | Feb 26, 2025 |
| Needham | Maintained | Buy | $14.00 | Feb 11, 2025 |
Frequently asked questions
What is the latest analyst rating on PCVX?
On Oct 12, 2026, Cantor Fitzgerald maintained Vaxcyte at Overweight with a price target of $120.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.